The regulation of muscle mass by endogenous glucocorticoids

被引:179
|
作者
Braun, Theodore P. [1 ,2 ]
Marks, Daniel L. [1 ]
机构
[1] Univ Washington, Med Ctr, Dept Internal Med, Seattle, WA 98195 USA
[2] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA
来源
FRONTIERS IN PHYSIOLOGY | 2015年 / 6卷
基金
加拿大健康研究院;
关键词
glucococorticoids; muscle; skeletal; HPA-axis; cachexia; catabolism; wasting; protein synthesis; 1 NULL MICE; SKELETAL-MUSCLE; GENE-EXPRESSION; OXIDATIVE STRESS; DNA-BINDING; PROTEIN-DEGRADATION; PROTEOLYTIC SYSTEM; UBIQUITIN LIGASES; CANCER CACHEXIA; ATROPHY INVOLVE;
D O I
10.3389/fphys.2015.00012
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Glucocorticoids are highly conserved fundamental regulators of energy homeostasis. In response to stress in the form of perceived danger or acute inflammation, glucocorticoids are released from the adrenal gland, rapidly mobilizing energy from carbohydrate, fat and protein stores. In the case of inflammation, mobilized protein is critical for the rapid synthesis of acute phase reactants and an efficient immune response to infection. While adaptive in response to infection, chronic mobilization can lead to a profound depletion of energy stores. Skeletal muscle represents the major body store of protein, and can become substantially atrophied under conditions of chronic inflammation. Glucocorticoids elicit the atrophy of muscle by increasing the rate of protein degradation by the ubiguitin-proteasome system and autophagy lysosome system. Protein synthesis is also suppressed at the level of translational initiation, preventing the production of new myofibrillar protein. Glucocorticoids also antagonize the action of anabolic regulators such as insulin further exacerbating the loss of protein and muscle mass. The loss of muscle mass in the context of chronic disease is a key feature of cachexia and contributes substantially to morbidity and mortality. A growing body of evidence demonstrates that glucocorticoid signaling is a common mediator of wasting, irrespective of the underlying initiator or disease state. This review will highlight fundamental mechanisms of glucocorticoid signaling and detail the mechanisms of glucocorticoid-induced muscle atrophy. Additionally, the evidence for glucocorticoids as a driver of muscle wasting in numerous disease states will be discussed. Given the burden of wasting diseases and the nodal nature of glucocorticoid signaling, effective anti-glucocorticoid therapy would be a valuable clinical tool. Therefore, the progress and potential pitfalls in the development of glucocorticoid antagonists for muscle wasting will be discussed.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] New insights into the endogenous regulation of glucocorticoids
    Hinz, B
    Hirschelmann, R
    PHARMAZIE, 1997, 52 (09): : 655 - 669
  • [2] Role of glucocorticoids in the molecular regulation of muscle wasting
    Menconi, Michael
    Fareed, Moin
    O'Neal, Patrick
    Poylin, Vitaliy
    Wei, Wei
    Hasselgren, Per-Olof
    CRITICAL CARE MEDICINE, 2007, 35 (09) : S602 - S608
  • [3] Regulation of airway smooth muscle α-actin expression by glucocorticoids
    Goldsmith, Adam M.
    Hershenson, Marc B.
    Wolbert, Miguel P.
    Bentley, J. Kelley
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2007, 292 (01) : L99 - L106
  • [4] THIGH MUSCLE MASS AND FUNCTION IN PATIENTS TREATED WITH GLUCOCORTICOIDS
    HORBER, FF
    SCHEIDEGGER, JR
    GRUNIG, BE
    FREY, FJ
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1985, 15 (06) : 302 - 307
  • [5] Endogenous production of glucocorticoids by lymphocytes provides a novel means for intracrine regulation
    Zhang, TY
    Ding, XH
    Daynes, RA
    FASEB JOURNAL, 2004, 18 (04): : A431 - A431
  • [6] Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids
    Bolton, C
    ONeill, JK
    Allen, SJ
    Baker, D
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 114 (01) : 74 - 80
  • [7] Regulation of endogenous melanocortin-4 receptor expression and signaling by glucocorticoids
    Sebag, Julien A.
    Hinkle, Patricia M.
    ENDOCRINOLOGY, 2006, 147 (12) : 5948 - 5955
  • [9] Endogenous Glucocorticoids and Bone
    Hong Zhou
    Mark S. Cooper
    Markus J. Seibel
    Bone Research, 2013, 1 : 107 - 119
  • [10] Endogenous Glucocorticoids and Bone
    Zhou, Hong
    Cooper, Mark S.
    Seibel, Markus J.
    BONE RESEARCH, 2013, 1 : 107 - 119